AMGEN Inc’s recent filing unveils that its VP, Finance & CAO Busch Matthew C. unloaded Company’s shares for reported $0.28 million on May 02 ’25. In the deal valued at $279.69 per share,1,000 shares were sold. As a result of this transaction, Busch Matthew C. now holds 4,034 shares worth roughly $1.07 million.
Then, Busch Matthew C. bought 1,000 shares, generating $281,440 in total proceeds.
Before that, Santos Esteban sold 8,711 shares. AMGEN Inc shares valued at $2,550,903 were divested by the EVP, Operations at a price of $292.84 per share. As a result of the transaction, Santos Esteban now holds 71,546 shares, worth roughly $19.02 million.
Wolfe Research began covering AMGN with “Peer perform” recommendation on November 15, 2024. Citigroup started covering the stock on November 14, 2024. It rated AMGN as “a Neutral”.
Price Performance Review of AMGN
On Friday, AMGEN Inc [NASDAQ:AMGN] saw its stock fall -2.28% to $265.86. Over the last five days, the stock has lost -5.46%. AMGEN Inc shares have risen nearly 2.00% since the year began. Nevertheless, the stocks have fallen -11.47% over the past one year. While a 52-week high of $346.85 was reached on 03/10/25, a 52-week low of $253.30 was recorded on 01/06/25. SMA at 50 days reached $297.72, while 200 days put it at $302.20.
Levels Of Support And Resistance For AMGN Stock
The 24-hour chart illustrates a support level at 263.19, which if violated will result in even more drops to 260.52. On the upside, there is a resistance level at 271.00. A further resistance level may holdings at 276.15. The Relative Strength Index (RSI) on the 14-day chart is 34.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -7.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.24%. Stochastics %K at 18.40% indicates the stock is a buying.
The most recent change occurred on October 17, 2024 when Bernstein began covering the stock and recommended ‘”an Outperform”‘ rating along with a $380 price target.
